Original
Triple inhaled therapy of formoterol/glycopyrrolate/budesonide reduces the use of oral corticosteroids and antibiotics during COPD exacerbations in real-world conditions
La triple terapia inhalada de formoterol/glucopirronio/budesonida reduce el uso de corticoides orales y antibióticos durante las exacerbaciones de la EPOC en condiciones de vida real
A. Calderón-Monteroa,
, J. de Miguel Diezb, R. de Simón Gutiérrezc, S. Campos Téllezd, A.D. Chacón Morenoe, R. Alonso Avilésf, N. González Alonsoa, A. Montero Solísg, D. Escribano Pardoh, on behalf of APyC group ◊
Autor para correspondencia
a Family Physician, Cerro del Aire Primary Care Health Center, Majadahonda, Madrid, Spain
b Pneumologist, Gregorio Marañon Hospital, Madrid, Spain
c Family Physician, Luis Vives Primary Care Health Center, Alcalá de Henares, Madrid, Spain
d Pneumologist, Gomez Ulla Hospital, Madrid, Spain
e Internist, Guadalajara Hospital, Guadalajara, Castilla La Mancha, Spain
f Emergency department, Valladolid Clinic Hospital, Valladolid, Castilla y León, Spain
g Family Physician, Canal de Panama Primary Care Health Center, Madrid, Spain
h Delicias Sur Primary Care Health Center, Zaragoza, Aragón, Spain
Leído
508
Vecesse ha leído el artículo
86
Total PDF
422
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 58 | 7 | 65 |
| 2025 11 | 347 | 61 | 408 |
| 2025 10 | 4 | 7 | 11 |
| 2025 7 | 2 | 0 | 2 |
| 2025 6 | 1 | 2 | 3 |
| 2025 5 | 1 | 2 | 3 |
| 2025 4 | 1 | 1 | 2 |
| 2025 3 | 2 | 3 | 5 |
| 2025 2 | 2 | 0 | 2 |
| 2025 1 | 4 | 3 | 7 |
